anlak storytelling
All kinds
Document kinds
Loading document kinds...

Primary corpus lens for browsing and insights. Selection lives in the URL.

All formats
Orientation
Loading formats...

Landscape, portrait, square, or unknown document geometry.

Unlock
slides · global inventory

Analyze Data

Slide function collection for the active corpus filters, with each row opening the slide detail view.

Search Insights JSON Unlock
Matching slides 58,039
Current window 43,921-43,950
Pages 1,935
Rows per page 30
Slide function: Analyze Dataclear collectionreset all
18 30 60

Slide function

43,921-43,950 of 58,039

filter-aware
17
The slide is part of an appendix, providing detailed clinical trial data for Imfinzi.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
18
The slide uses a standard clinical trial registry format.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
19
The slide is part of an appendix section detailing clinical trial status for specific drug assets.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
20
The slide is part of an appendix, likely from a pharmaceutical investor presentation.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Cost Of Inaction1 hit
21
The slide uses a vertical tab structure on the right to categorize the therapeutic area (Oncology).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
22
The slide provides a structured overview of three specific clinical trials: DESTINY-Gastric04, 06, and 03.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
23
The slide is part of an appendix, indicated by the footer and the 'Other' tab in the right-hand navigation.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
24
The slide uses a standard clinical trial pipeline table format.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
25
The slide uses a standard clinical trial registry format for reporting pipeline progress.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
26
The slide uses a standard clinical trial registry format for portfolio tracking.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
27
The slide is part of an appendix, specifically detailing clinical trial status for a specific drug.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
28
The slide provides a structured overview of four specific clinical trials (LAURA, ADAURA2, NeoADAURA, FLAURA2).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
29
The slide provides a structured overview of five specific clinical trials (SAFFRON, SANOVO, SACHI, SAVANNAH, ORCHARD) including patient counts and trial arms.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
30
The slide uses a color-coded sidebar on the right to categorize the drug's development stage (Oncology).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
31
The slide provides a structured overview of five specific clinical trials (TROPION-Breast01 through 05).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
32
The slide is part of an appendix, indicated by the footer and the 'Appendix' label.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
34
The slide is part of an appendix, indicated by the page number 34 and the 'Appendix: Glossary' link at the bottom.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
35
The slide is part of an appendix section, indicated by the page number and glossary link.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
36
The slide is part of an appendix, detailing specific trial designs, patient counts, and status for TROPION-PanTumor trials.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
37
The slide uses a vertical navigation bar on the right to indicate the drug's development stage (Late-stage development) and therapeutic area (Oncology).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
38
Includes trial identifiers (NCT numbers) and status timelines.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
39
The slide is an appendix page detailing clinical trial pipeline data for a specific drug.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
40
The table lists five distinct clinical trials (SERENA-2, SERENA-3, NCT04541433, SERENA-1, NCT04818632).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · SolutionLoop · Golden Circle1 hit
41
The slide is part of an appendix section detailing clinical trial pipelines.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
42
The slide is part of an appendix, specifically detailing late-stage development assets.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
43
The slide is part of an appendix, providing detailed clinical trial data for a specific asset.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
44
The slide provides a structured overview of four specific clinical trials (EvoPAR-Prostate01, EvoPAR-Breast01, PETRA, PETRANHA).AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
45
The slide is part of an appendix, providing specific clinical trial data for a drug candidate.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
46
The slide is an appendix page detailing the clinical development pipeline for a specific drug candidate.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit
47
Slide 47 of a presentation deck.AstraZeneca | Results Presentation Deck | 157 slides · AstraZeneca
Conference presentation Investor relations Beat · Solution1 hit